Skip to main content
Erschienen in: Archives of Virology 10/2014

01.10.2014 | Original Article

Isolation and characterization of a novel bacteriophage against Mycobacterium avium subspecies paratuberculosis

verfasst von: Simone Basra, Hany Anany, Lioubov Brovko, Andrew M. Kropinski, Mansel W. Griffiths

Erschienen in: Archives of Virology | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Mycobacterium avium subspecies paratuberculosis (MAP), the causative agent of Johne’s disease, has a doubling time of 24 hours, making rapid detection very difficult. Mycobacteriophages can be used in the detection of disease-causing mycobacteria such as MAP. Isolation and sequencing the genomes of lytic MAP bacteriophages are important preliminary steps towards designing phage-based rapid detection assays for this bacterium. A simple optimized protocol was developed to allow reproducible production of confluent growth of MAP on plates within four to six weeks of incubation at 30 °C. This protocol was applied to the screening of environmental and fecal samples for bacteriophages inhibiting the growth of MAP. As a result, a lytic phage, vB_MapS_FF47, was isolated from bovine feces. FF47 contains a double-stranded DNA genome ~48 kb in length with 73 protein coding sequences. It does not carry temperate or known virulence genes. This phage was shown to be most closely related to Mycobacterium phage Muddy, isolated in South Africa, and Gordonia phage GTE2; however, it could not infect any of the tested Gordonia, Rhodococcus, or Nocardia spp. that GTE2 could. The protocols that were developed for growth and phage isolation have potential applications in a high-throughput screening for compounds inhibiting the growth of MAP. This work describes the first time that a phage was isolated against M. paratuberculosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Over K, Crandall P, O’Bryan C, Ricke S (2011) Current perspectives on Mycobacterium avium subsp. paratuberculosis, Johne’s disease, and Crohn’s disease: a review. Crit Rev Microbiol 37:141–156PubMedCrossRef Over K, Crandall P, O’Bryan C, Ricke S (2011) Current perspectives on Mycobacterium avium subsp. paratuberculosis, Johne’s disease, and Crohn’s disease: a review. Crit Rev Microbiol 37:141–156PubMedCrossRef
3.
Zurück zum Zitat Mihajlovic B, Klassen M, Springthorpe S, Couture H, Farber J (2011) Assessment of food as a source of exposure to Mycobacterium avium subspecies paratuberculosis (MAP). J Food Prot 73:1357–1397 Mihajlovic B, Klassen M, Springthorpe S, Couture H, Farber J (2011) Assessment of food as a source of exposure to Mycobacterium avium subspecies paratuberculosis (MAP). J Food Prot 73:1357–1397
5.
Zurück zum Zitat McKenna S, Keefe G, Tiwari A, VanLeeuwen J, Barkema H (2006) Johne’s disease in Canada part II: disease impacts, risk factors, and control programs for dairy producers. Can Vet J 47:1089–1099PubMedPubMedCentral McKenna S, Keefe G, Tiwari A, VanLeeuwen J, Barkema H (2006) Johne’s disease in Canada part II: disease impacts, risk factors, and control programs for dairy producers. Can Vet J 47:1089–1099PubMedPubMedCentral
6.
Zurück zum Zitat Kreeger J (1991) Ruminant paratuberculosis—a century of progress and frustration. J Vet Diagn Invest 3:373–383PubMedCrossRef Kreeger J (1991) Ruminant paratuberculosis—a century of progress and frustration. J Vet Diagn Invest 3:373–383PubMedCrossRef
7.
Zurück zum Zitat Timms VJ, Gehringer MM, Mitchell HH, Daskalopoulos G, Neilan BA (2011) How accurately can we detect Mycobacterium avium subsp. paratuberculosis infection? J Microbiol Methods 85:1–8PubMedCrossRef Timms VJ, Gehringer MM, Mitchell HH, Daskalopoulos G, Neilan BA (2011) How accurately can we detect Mycobacterium avium subsp. paratuberculosis infection? J Microbiol Methods 85:1–8PubMedCrossRef
8.
Zurück zum Zitat Ratledge C (1982) Lipids: cell composition, fatty acid biosyntheses. In: Ratledge C, Standford JL (eds) The biology of the mycobacteria, 1st edn. Academic Press, London, p 53 Ratledge C (1982) Lipids: cell composition, fatty acid biosyntheses. In: Ratledge C, Standford JL (eds) The biology of the mycobacteria, 1st edn. Academic Press, London, p 53
9.
Zurück zum Zitat De Juan L, Álvarez J, Romero B, Bezos J, Castellanos E, Aranaz A, Mateos A, Dominquez L (2006) Comparison of four different culture media for isolation and growth of type II and type I/III Mycobacterium avium subsp. paratuberculosis strains isolated from cattle and goats. Appl Environ Microbiol 72:5927–5932PubMedCrossRefPubMedCentral De Juan L, Álvarez J, Romero B, Bezos J, Castellanos E, Aranaz A, Mateos A, Dominquez L (2006) Comparison of four different culture media for isolation and growth of type II and type I/III Mycobacterium avium subsp. paratuberculosis strains isolated from cattle and goats. Appl Environ Microbiol 72:5927–5932PubMedCrossRefPubMedCentral
11.
Zurück zum Zitat Adams MH (1959) Bacteriophages. Interscience Publishers Inc, New York Adams MH (1959) Bacteriophages. Interscience Publishers Inc, New York
12.
Zurück zum Zitat Kropinski AM, Mazzocco A, Waddell TE, Lingohr E, Johnson RP (2009) Enumeration of bacteriophages by double agar overlay plaque assay. In: Kropinski AM, Clokie MRJ (eds) Methods in molecular biology, 1st edn. Humana Press, New Jersey, pp 69–76 Kropinski AM, Mazzocco A, Waddell TE, Lingohr E, Johnson RP (2009) Enumeration of bacteriophages by double agar overlay plaque assay. In: Kropinski AM, Clokie MRJ (eds) Methods in molecular biology, 1st edn. Humana Press, New Jersey, pp 69–76
13.
Zurück zum Zitat White A, Knight V (1958) Effect of tween 80 and serum on the interaction of mycobacteriophage D-29 with certain mycobacterial species. Am Rev Tuberc 77:134–145PubMed White A, Knight V (1958) Effect of tween 80 and serum on the interaction of mycobacteriophage D-29 with certain mycobacterial species. Am Rev Tuberc 77:134–145PubMed
14.
Zurück zum Zitat Tokunaga T, Nakamura RM (1968) Infection of competent Mycobacterium smegmatis with deoxyribonucleic acid extracted from bacteriophage B1. J Virol 2:110–117PubMedPubMedCentral Tokunaga T, Nakamura RM (1968) Infection of competent Mycobacterium smegmatis with deoxyribonucleic acid extracted from bacteriophage B1. J Virol 2:110–117PubMedPubMedCentral
15.
Zurück zum Zitat Gadagkar R, Gopinathan K (1978) Inhibition of DNA injection from myocobacteriophage 13 by tween-80. Virology 91:487–488PubMedCrossRef Gadagkar R, Gopinathan K (1978) Inhibition of DNA injection from myocobacteriophage 13 by tween-80. Virology 91:487–488PubMedCrossRef
16.
Zurück zum Zitat Sambrook J, Fritsch E, Maniatis T (1989) Molecular cloning: a laboratory manual, vol 3, 2nd edn. Cold Spring Harbor Laboratory Press, New York Sambrook J, Fritsch E, Maniatis T (1989) Molecular cloning: a laboratory manual, vol 3, 2nd edn. Cold Spring Harbor Laboratory Press, New York
18.
Zurück zum Zitat Sambrook P, Fritsch E, Maniatis T (1989) Molecular cloning: a Laboratory Manual, vol 1, 2nd edn. Cold Spring Harbor Laboratory Press, New York Sambrook P, Fritsch E, Maniatis T (1989) Molecular cloning: a Laboratory Manual, vol 1, 2nd edn. Cold Spring Harbor Laboratory Press, New York
19.
Zurück zum Zitat Anany H, Lingohr E, Villegas A, Ackermann H, She Y, Griffiths M, Kropinski A (2011) A Shigella boydii bacteriophage which resembles Salmonella phage ViI. Virol J 19:242CrossRef Anany H, Lingohr E, Villegas A, Ackermann H, She Y, Griffiths M, Kropinski A (2011) A Shigella boydii bacteriophage which resembles Salmonella phage ViI. Virol J 19:242CrossRef
20.
Zurück zum Zitat Shine J, Dalgarno L (1974) The 3′-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites. Proc Natl Acad Sci USA 71:1342–1346PubMedCrossRefPubMedCentral Shine J, Dalgarno L (1974) The 3′-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites. Proc Natl Acad Sci USA 71:1342–1346PubMedCrossRefPubMedCentral
21.
Zurück zum Zitat Maarek Y, Jacovi M, Shtalhaim M, Ur S, Zernik D, Ben-Shaul I (1997) WebCutter: a system for dynamic and tailorable site mapping. Comput Netw ISDN 29:1269–1279CrossRef Maarek Y, Jacovi M, Shtalhaim M, Ur S, Zernik D, Ben-Shaul I (1997) WebCutter: a system for dynamic and tailorable site mapping. Comput Netw ISDN 29:1269–1279CrossRef
22.
Zurück zum Zitat Grant J, Stothard P (2008) The CGView Server: a comparative genomics tool for circular genomes. Nucleic Acids Res 36:181–184CrossRef Grant J, Stothard P (2008) The CGView Server: a comparative genomics tool for circular genomes. Nucleic Acids Res 36:181–184CrossRef
23.
Zurück zum Zitat Sonnhammer E, Von Heijne G, Krogh A (1998) A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Bio 6:175–182 Sonnhammer E, Von Heijne G, Krogh A (1998) A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Bio 6:175–182
24.
25.
Zurück zum Zitat Turner D, Reynolds D, Seto D, Mahadevan P (2013) CoreGenes3.5: a webserver for the determination of core genes from sets of viral and small bacterial genomes. BMC Res Notes 6:140PubMedCrossRefPubMedCentral Turner D, Reynolds D, Seto D, Mahadevan P (2013) CoreGenes3.5: a webserver for the determination of core genes from sets of viral and small bacterial genomes. BMC Res Notes 6:140PubMedCrossRefPubMedCentral
26.
Zurück zum Zitat Pedulla M et al (2003) Origins of highly mosaic mycobacteriophage genomes. Cell 113:171–182PubMedCrossRef Pedulla M et al (2003) Origins of highly mosaic mycobacteriophage genomes. Cell 113:171–182PubMedCrossRef
27.
Zurück zum Zitat Stanley E, Mole R, Smith R, Glenn S, Barer M, McGowan M, Rees C (2007) Development of a new, combined rapid method using phage and PCR for detection and identification of viable Mycobacterium paratuberculosis bacteria within 48 hours. Appl Environ Microbiol 73:1851–1857PubMedCrossRefPubMedCentral Stanley E, Mole R, Smith R, Glenn S, Barer M, McGowan M, Rees C (2007) Development of a new, combined rapid method using phage and PCR for detection and identification of viable Mycobacterium paratuberculosis bacteria within 48 hours. Appl Environ Microbiol 73:1851–1857PubMedCrossRefPubMedCentral
28.
Zurück zum Zitat Gwozdz J (2008) Paratuberculosis (Johne’s disease). In: World Organisation for Animal Health (ed) OIE terrestrial manual, pp 276–291 Gwozdz J (2008) Paratuberculosis (Johne’s disease). In: World Organisation for Animal Health (ed) OIE terrestrial manual, pp 276–291
30.
Zurück zum Zitat Bardarov S, Kriakov J, Carriere C, Yu S, Vaamonde C, McAdam R, Bloom B, Hatfull G, Jacobs W (1997) Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 94:10961–10966PubMedCrossRefPubMedCentral Bardarov S, Kriakov J, Carriere C, Yu S, Vaamonde C, McAdam R, Bloom B, Hatfull G, Jacobs W (1997) Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 94:10961–10966PubMedCrossRefPubMedCentral
31.
Zurück zum Zitat Shafia F, Thompson T (1964) Calcium ion requirement for proliferation of bacteriophage φμ-4. J Bacteriol 88:293–296PubMedPubMedCentral Shafia F, Thompson T (1964) Calcium ion requirement for proliferation of bacteriophage φμ-4. J Bacteriol 88:293–296PubMedPubMedCentral
32.
33.
Zurück zum Zitat Petrovski S, Seviour R, Tillett D (2011) Characterization of the genome of the polyvalent lytic bacteriophage GTE2, which has potential for biocontrol of Gordonia-, Rhodococcus-, and Nocardia-stabilized. Appl Environ Microbiol 77:3923–3929PubMedCrossRefPubMedCentral Petrovski S, Seviour R, Tillett D (2011) Characterization of the genome of the polyvalent lytic bacteriophage GTE2, which has potential for biocontrol of Gordonia-, Rhodococcus-, and Nocardia-stabilized. Appl Environ Microbiol 77:3923–3929PubMedCrossRefPubMedCentral
34.
Zurück zum Zitat Roberts RJ, Vincze T, Posfai J, Macelis D (2010) REBASE—a database for DNA restriction and modification: enzymes, genes and genomes. Nucleic Acids Res 38(Database issue):D234–D236PubMedCrossRefPubMedCentral Roberts RJ, Vincze T, Posfai J, Macelis D (2010) REBASE—a database for DNA restriction and modification: enzymes, genes and genomes. Nucleic Acids Res 38(Database issue):D234–D236PubMedCrossRefPubMedCentral
35.
Zurück zum Zitat Nunes-Düby SE, Kwon HJ, Tirumalai RS, Ellenberger T, Landy A (1998) Similarities and differences among 105 members of the Int family of site-specific recombinases. Nucleic Acids Res 26:391–406PubMedCrossRefPubMedCentral Nunes-Düby SE, Kwon HJ, Tirumalai RS, Ellenberger T, Landy A (1998) Similarities and differences among 105 members of the Int family of site-specific recombinases. Nucleic Acids Res 26:391–406PubMedCrossRefPubMedCentral
36.
Zurück zum Zitat Boyd EF, Brüssow H (2002) Common themes among bacteriophage-encoded virulence factors and diversity among the bacteriophages involved. Trends Microbiol 10:521–529PubMedCrossRef Boyd EF, Brüssow H (2002) Common themes among bacteriophage-encoded virulence factors and diversity among the bacteriophages involved. Trends Microbiol 10:521–529PubMedCrossRef
37.
Zurück zum Zitat Rawlings ND, Waller M, Barrett AJ, Bateman A (2013) MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res 42:D503–D509PubMedCrossRefPubMedCentral Rawlings ND, Waller M, Barrett AJ, Bateman A (2013) MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res 42:D503–D509PubMedCrossRefPubMedCentral
38.
Zurück zum Zitat Paradis-Bleau C, Cloutier I, Lemieux L, Sanschagrin F, Laroche J, Auger M, Garnier A, Levesque RC (2007) Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage phiKZ gp144 lytic transglycosylase. FEMS Microbiol Lett 266:201–209PubMedCrossRef Paradis-Bleau C, Cloutier I, Lemieux L, Sanschagrin F, Laroche J, Auger M, Garnier A, Levesque RC (2007) Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage phiKZ gp144 lytic transglycosylase. FEMS Microbiol Lett 266:201–209PubMedCrossRef
39.
Zurück zum Zitat Miroshnikov KA, Faizullina NM, Sykilinda NN, Mesyanzhinov VV (2006) Properties of the endolytic transglycosylase encoded by gene 144 of Pseudomonas aeruginosa bacteriophage phiKZ. Biochemistry (Mosc) 71:300–305CrossRef Miroshnikov KA, Faizullina NM, Sykilinda NN, Mesyanzhinov VV (2006) Properties of the endolytic transglycosylase encoded by gene 144 of Pseudomonas aeruginosa bacteriophage phiKZ. Biochemistry (Mosc) 71:300–305CrossRef
40.
Zurück zum Zitat Käll L, Krogh A, Sonnhammer ELL (2004) A combined transmembrane topology and signal peptide prediction method. J Mol Biol 338:1027–1036PubMedCrossRef Käll L, Krogh A, Sonnhammer ELL (2004) A combined transmembrane topology and signal peptide prediction method. J Mol Biol 338:1027–1036PubMedCrossRef
41.
Zurück zum Zitat Omasits U, Ahrens CH, Müller S, Wollscheid B (2013) Protter: interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics. doi:10.1093/bioinformatics/btt607 Omasits U, Ahrens CH, Müller S, Wollscheid B (2013) Protter: interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics. doi:10.​1093/​bioinformatics/​btt607
42.
Zurück zum Zitat Catalão MJ, Gil F, Moniz-Pereira J, São-José C, Pimentel M (2013) Diversity in bacterial lysis systems: bacteriophages show the way. FEMS Microbiol Rev 37:554–571PubMedCrossRef Catalão MJ, Gil F, Moniz-Pereira J, São-José C, Pimentel M (2013) Diversity in bacterial lysis systems: bacteriophages show the way. FEMS Microbiol Rev 37:554–571PubMedCrossRef
43.
Zurück zum Zitat Nelson DC, Schmelcher M, Rodriguez-Rubio L, Klumpp J, Pritchard DG, Dong S, Donovan DM (2012) Endolysins as antimicrobials. Adv Virus Res 83:299–365PubMedCrossRef Nelson DC, Schmelcher M, Rodriguez-Rubio L, Klumpp J, Pritchard DG, Dong S, Donovan DM (2012) Endolysins as antimicrobials. Adv Virus Res 83:299–365PubMedCrossRef
45.
Zurück zum Zitat Hatfull G, Cresawn S, Hendrix R (2008) Comparative genomics of the mycobacteriophages: insights into bacteriophage evolution. Res Microbiol 159:332–339PubMedCrossRefPubMedCentral Hatfull G, Cresawn S, Hendrix R (2008) Comparative genomics of the mycobacteriophages: insights into bacteriophage evolution. Res Microbiol 159:332–339PubMedCrossRefPubMedCentral
46.
Zurück zum Zitat Froman S, Will D, Bogen E (1954) Bacteriophage active against virulent Mycobacterium tuberculosis—I. Isolation and activity. Am J Public Health Nations Health 44:1326–1333PubMedCrossRefPubMedCentral Froman S, Will D, Bogen E (1954) Bacteriophage active against virulent Mycobacterium tuberculosis—I. Isolation and activity. Am J Public Health Nations Health 44:1326–1333PubMedCrossRefPubMedCentral
47.
Zurück zum Zitat Foley-Thomas E, Whipple D, Bermudez L, Barletta R (1995) Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis. Microbiology 141:1173–1181PubMedCrossRef Foley-Thomas E, Whipple D, Bermudez L, Barletta R (1995) Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis. Microbiology 141:1173–1181PubMedCrossRef
48.
49.
Zurück zum Zitat Carlton RM, Noordman WH, Biswas B, de Meester ED, Loessner MJ (2005) Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul Toxicol Pharmacol 43:301–312PubMedCrossRef Carlton RM, Noordman WH, Biswas B, de Meester ED, Loessner MJ (2005) Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul Toxicol Pharmacol 43:301–312PubMedCrossRef
50.
Zurück zum Zitat Lavigne R, Seto D, Mahadevan P, Ackermann H-W, Kropinski AM (2008) Unifying classical and molecular taxonomic classification: analysis of the Podoviridae using BLASTP-based tools. Res Microbiol 159:406–414PubMedCrossRef Lavigne R, Seto D, Mahadevan P, Ackermann H-W, Kropinski AM (2008) Unifying classical and molecular taxonomic classification: analysis of the Podoviridae using BLASTP-based tools. Res Microbiol 159:406–414PubMedCrossRef
51.
Zurück zum Zitat Lavigne R, Darius P, Summer EJ, Seto D, Mahadevan P, Nilsson AS, Ackermann HW, Kropinski AM (2009) Classification of Myoviridae bacteriophages using protein sequence similarity. BMC Microbiol 9:224PubMedCrossRefPubMedCentral Lavigne R, Darius P, Summer EJ, Seto D, Mahadevan P, Nilsson AS, Ackermann HW, Kropinski AM (2009) Classification of Myoviridae bacteriophages using protein sequence similarity. BMC Microbiol 9:224PubMedCrossRefPubMedCentral
Metadaten
Titel
Isolation and characterization of a novel bacteriophage against Mycobacterium avium subspecies paratuberculosis
verfasst von
Simone Basra
Hany Anany
Lioubov Brovko
Andrew M. Kropinski
Mansel W. Griffiths
Publikationsdatum
01.10.2014
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 10/2014
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-014-2122-3

Weitere Artikel der Ausgabe 10/2014

Archives of Virology 10/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.